WCN26-2893 THE MORE SEVERE INITIAL eGFR DIP AFTER ADMINISTRATION OF SGLT2I, THE BETTER RENOPROTECTIVE EFFECT

Read full text Summarise with VIRAT
Authors: Sawako Kato, Keisuke Murakami, Yoshihiro Nakamura, Shoichi Maruyama
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

In the FAGOTTO trial (jRCTs041200069) to evaluate changes of renal hemodynamics on initial glomerular filtration rate (GFR) dip induced by Sodium-glucose cotransporter 2 inhibitors (SGLT2i) in patients (pts) with type 2 diabetic kidney disease (DKD) and moderate renal dysfunction, we reported that renoprotective effects of SGLT2i may be due to mechanisms other than renal hemodynamic changes. In this follow-up survey, we evaluated if severity of initial GFR dip might associate tubulointerstitial biomarker and also one year-eGFR slope.

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Diabetes Treatment and Management Acute Kidney Injury Research

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104599–104599
Publication date
25 March 2026
Language
EN